These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7237793)

  • 21. Quantitative histophotometry analysing significant inductive and alterative effects of aminoglycoside application (gentamicin, tobramycin, amikacin) upon tubular kidney proteins.
    Heinert G; Wyrobnik J; Scherberich J; Mondorf W; Weber W
    Urol Int; 1982; 37(4):221-35. PubMed ID: 6182668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 125I-Radioimmunoassay of amikacin and comparison with a microbioassay.
    Stevens P; Young LS; Hewitt WL
    J Antibiot (Tokyo); 1976 Aug; 29(8):829-32. PubMed ID: 1033175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.
    Moellering RC; Wennersten C; Kunz LJ; Poitras JW
    Am J Med; 1977 Jun; 62(6):873-81. PubMed ID: 868901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incorporation, release and in-vitro antibacterial activity of liposomal aminoglycosides against Pseudomonas aeruginosa.
    Omri A; Ravaoarinoro M; Poisson M
    J Antimicrob Chemother; 1995 Oct; 36(4):631-9. PubMed ID: 8591937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
    Reynolds AV; Hamilton-Miller JM; Brumfitt W
    Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
    Drugeon HB; Courtieu AL
    Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some aspects of aminoglycoside antibiotic measurement.
    Botha P; Berman PA; Elisha G; Callanan JJ
    S Afr Med J; 1979 Aug; 56(6):211-3. PubMed ID: 550471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The distribution of aminoglycoside antibiotics into the lymph and pancreatic fluid in dogs (author's transl)].
    Lee YG
    Jpn J Antibiot; 1980 May; 33(5):558-73. PubMed ID: 7431657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitation of serum tobramycin concentration using high-pressure liquid chromatography.
    Maitra SK; Yoshikawa TT; Hansen JL; Schotz MC; Guze LB
    Am J Clin Pathol; 1979 Apr; 71(4):428-32. PubMed ID: 443201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
    DiPersio JR; Krafczyk TL
    Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diffusion of amikacin in the lungs].
    Saux MC; Crockett R; Fourtillan JB; Leng B; Couraud L
    Pathol Biol (Paris); 1986 Feb; 34(2):113-7. PubMed ID: 3517776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal accumulation of amikacin, tobramycin and gentamycin in the rat.
    Nieminen L; Kasanen A; Kangas L; Sairio E; Anttila M
    Experientia; 1978 Oct; 34(10):1335-6. PubMed ID: 738411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of amikacin and kanamycin in serum using a simple and validated LC-MS/MS method.
    Dijkstra JA; Sturkenboom MG; Hateren Kv; Koster RA; Greijdanus B; Alffenaar JW
    Bioanalysis; 2014 Aug; 6(16):2125-33. PubMed ID: 25331857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global and effective synergism of amikacin, gentamicin or tobramycin when combined with carbenicillin against Pseudomonas aeruginosa.
    Ximenes J; Hirai CK; Takenaka IM
    J Int Med Res; 1979; 7(5):375-8. PubMed ID: 115732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.
    Moore RD; Smith CR; Lietman PS
    J Infect Dis; 1984 Mar; 149(3):443-8. PubMed ID: 6715900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
    Drasar FA; Farrell W; Maskell J; Williams JD
    Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assay of gentamicin and tobramycin in sera of patients by gas-liquid chromatography.
    Mayhew JW; Gorbach SL
    Antimicrob Agents Chemother; 1978 Dec; 14(6):851-55. PubMed ID: 369455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro evaluations of amikacin: an assessment of the currently used methods of disk diffusion and dilution susceptibility, antimicrobial synergy, and the measurement of amikacin concentrations.
    Jones RN
    Am J Med; 1986 Jun; 80(6B):88-97. PubMed ID: 3524220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gentamicin-resistant gram-negative bacilli in hospital patients. Part II. In vitro aspects including susceptibility to tobramycin and amikacin.
    Block CS; Fabian B; Robinson RG
    S Afr Med J; 1978 Mar; 53(11):396-99. PubMed ID: 675374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.